GlassScriptPhysician profile
Itshac Ben-Dor
NPI 1932356961
$25,472.26
in general payments reported to CMS, 2019-2025
43 companies · $2,840 in 2025
The $2,840 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,425 · 2020: $1,355 · 2021: $3,165 · 2022: $3,331 · 2023: $2,632 · 2024: $9,724 · 2025: $2,840.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,758 · Consulting Fee: $4,550 · Travel and Lodging: $2,789 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,758.24 |
| Consulting Fee | $4,550.00 |
| Travel and Lodging | $2,788.74 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,376.48 | 2019-2025 | Avvigo Guidance System, Watchman Access System, General - Vascular Access |
| Abbott Laboratories | $3,826.55 | 2019-2025 | Triclip, Dragonfly Opstar, Coroflow |
| Medtronic, INC. | $3,549.87 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Cordis US Corp. | $2,400.00 | 2024 | Selution Slrpcta |
| Cathworks, INC. | $1,500.00 | 2024 | Ffrangio |
| Ancora Heart, INC. | $1,469.00 | 2021 | |
| Teleflex LLC | $980.57 | 2020-2025 | Manta, Guideliner, Turnpike |
| Amgen INC. | $843.88 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $782.16 | 2019-2023 | |
| Arrow International, INC. | $650.00 | 2024 | |
| Medtronic Vascular, INC. | $477.17 | 2019-2020 | |
| Terumo Medical Corporation | $439.58 | 2020-2025 | Angio-Seal |
| Abiomed | $408.88 | 2022-2024 | Impella |
| Edwards Lifesciences Corporation | $360.00 | 2019-2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $321.66 | 2019-2025 | Camzyos, Eliquis |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $314.39 | 2019-2022 | |
| Pfizer INC. | $310.59 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $299.37 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $242.16 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Jenavalve Technology, INC. | $238.10 | 2022 | |
| Asahi Intecc USA, INC. | $219.09 | 2019-2025 | Asahi Ptca Guide Wire, Asahi Coronary Wires, Asahi Peripheral Vascular Wires |
| Cook Medical LLC | $206.38 | 2019-2025 | Zilver Ptx |
| Chiesi USA, INC. | $173.18 | 2019-2022 | |
| Shockwave Medical, INC | $152.45 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $150.00 | 2019 | |
| Biotronik INC. | $147.59 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $124.64 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $119.41 | 2019-2024 | |
| Siemens Medical Solutions USA, INC. | $88.02 | 2020 | |
| Cardiva Medical, INC. | $53.15 | 2019-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Celonova Biosciences, INC. | $49.20 | 2020 | |
| Recor Medical INC | $42.76 | 2025 | Paradise Ultrasound Renal Denervation System |
| Cardinal Health 200 LLC | $36.54 | 2019 | |
| Kestra Medical Technology Services, INC. | $27.09 | 2025 | Assure Wcd |
| Bard Peripheral Vascular, INC. | $25.62 | 2020 | |
| Atricure, INC. | $19.60 | 2021 | |
| Silk Road Medical, INC. | $17.60 | 2019 | |
| W. L. Gore & Associates, INC. | $15.23 | 2019 | |
| Toray International America INC. | $14.30 | 2025 | Inoue Balloon Catheter |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Itshac Ben-Dor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.